Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

The tool is said to predict “off-target” effects for seven drugs that could aid in cellular hypertrophy prevention.

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

Learn how drug absorption and predictive modeling drive advancements in pharmaceuticals and precision medicine.

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

The preclinical evaluation of drug-induced cardiotoxicity is an important stage in the drug development process; however, traditional methods for screening drug candidates, such as cardiomyocyte-based ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

Amid the ethical and legal arguments, a fundamental question remains: How much do we truly understand about the drugs used in ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter ...